Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04506970 · ClinicalTrials.gov registry record
Predicting Placental Pathologies by Ultrasound Imaging
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT04506970: Completed study, sponsored by Mayo Clinic.
NCT04506970 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04506970 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Intrauterine growth restriction (IUGR) is caused when the placenta cannot provide enough nutrients to allow normal growth of the fetus during pregnancy. It is unclear why IUGR happens, but an increase in inflammatory T cells in the placenta known as villitis of unknown etiology (VUE) is observed in many IUGR infants. The investigators aim to develop ultrasound methods for diagnosing VUE to understand it's role in IUGR.
Interventions
- DIAGNOSTIC_TEST Comprehensive Doppler Ultrasound of the Placenta
- OTHER Verasonics Ultrasound scanner (ultra-sensitive Doppler imaging)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-09-27 |
| Est. Completion | 2023-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04506970
The ClinicalTrials.gov registry entry for NCT04506970 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Comprehensive Doppler Ultrasound of the Placenta is the first listed.
NCT04506970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04506970 about?
NCT04506970 is a clinical study titled "Predicting Placental Pathologies by Ultrasound Imaging". Intrauterine growth restriction (IUGR) is caused when the placenta cannot provide enough nutrients to allow normal growth of the fetus during pregnancy. It is unclear why IUGR happens, but an increase in inflammatory T cells in the placenta known as villitis of unknown etiology (VUE) is observed in ...
What is the current status of trial NCT04506970?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-09-27. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT04506970?
The interventions under investigation include: Comprehensive Doppler Ultrasound of the Placenta (DIAGNOSTIC_TEST), Verasonics Ultrasound scanner (ultra-sensitive Doppler imaging) (OTHER).
Who is sponsoring clinical trial NCT04506970?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.